title: Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancer.
abstract: OBJECTIVE
  Staging of lung cancer is typically performed with fluorodeoxyglucose-positron emission tomography-computed tomography (FDG-PET/CT); however, false positive PET scans can occur due to inflammatory disease. The CT scan is used for anatomic registration and attenuation correction. Herein, we evaluated x-ray attenuation (XRA) within nodes on CT and correlated this with the presence of malignancy in an orthotopic lung cancer model in rats.
  
  
  METHODS
  1×10⁶ NCI-H460 cells were injected transthoracically in six National Institutes of Health nude rats and six animals served as controls. After two weeks, animals were sacrificed; lymph nodes were extracted and scanned with a micro-CT to determine their XRA prior to histologic analysis.
  
  
  RESULTS
  Median CT density in malignant lymph nodes (n=20) was significantly higher than benign lymph nodes (n=12; P = 0.018). Short-axis diameter of metastatic lymph nodes was significantly different than benign nodes (3.4 mm vs. 2.4 mm; P = 0.025). Area under the curve for malignancy was higher for density-based lymph node analysis compared with size measurements (0.87 vs. 0.7).
  
  
  CONCLUSIONS
  XRA of metastatic mediastinal lymph nodes is significantly higher than benign nodes in this lung cancer model. This suggests that information on nodal density may be useful when used in combination with the results of FDG-PET in determining the likelihood of malignant adenopathy.
authors.affiliation: Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany. frederik@egiesel.com.
authors.forename: Paul
authors.initials: P
authors.lastname: Flechsig
authors.forename: Peter
authors.initials: P
authors.lastname: Choyke
authors.forename: Clemens
authors.initials: C
authors.lastname: Kratochwil
authors.forename: Arne
authors.initials: A
authors.lastname: Warth
authors.forename: Gerald
authors.initials: G
authors.lastname: Antoch
authors.forename: Tim
authors.initials: T
authors.lastname: Holland Letz
authors.forename: Daniel
authors.initials: D
authors.lastname: Rath
authors.forename: Viktoria
authors.initials: V
authors.lastname: Eichwald
authors.forename: Peter E
authors.initials: PE
authors.lastname: Huber
authors.forename: Hans-Ulrich
authors.initials: HU
authors.lastname: Kauczor
authors.forename: Uwe
authors.initials: U
authors.lastname: Haberkorn
authors.forename: Frederik L
authors.initials: FL
authors.lastname: Giesel
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D019788:Fluorodeoxyglucose F18 / Q000032:analysis; D064593:Heterografts; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D008198:Lymph Nodes / Q000000981:diagnostic imaging* / Q000473:pathology; D008297:Male; D009368:Neoplasm Transplantation; D000072078:Positron Emission Tomography Computed Tomography; D019275:Radiopharmaceuticals / Q000032:analysis; D051381:Rats; D011923:Rats, Nude; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18